((自动化翻译由路透提供，请见免责声明 ))
路透纽约10月22日 - 激进对冲基金Starboard Value的首席投资官杰弗里-史密斯（Jeffrey Smith）周二表示，制药商辉瑞公司 的董事会需要让管理层对其业绩不佳负责。
他说："我们衡量生产大片药物是否成功的标准是业绩记录。这里的业绩记录并不好，"史密斯在纽约举行的13D Monitor主动-被动投资者峰会上说。
Starboard 已在辉瑞公司建立了 10 亿美元的仓位，但此前并未详细说明对这家制药商的担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.